Loading...
TONX is not a good buy right now for an impatient investor. The chart is still technically bearish (stacked bearish moving averages and MACD below zero), and there are no Intellectia proprietary buy signals to override that. If you already own it, this is a HOLD into the near-term catalysts (management/board changes and upcoming earnings), but as a fresh entry today the risk/reward is not attractive until price reclaims ~2.69 (pivot) and holds above it.
Trend/structure: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), signaling a prevailing downtrend. Momentum: MACD histogram is negative (-0.00481) and still below zero (bearish), though contracting (selling pressure easing but not reversed). RSI(6) at ~42.5 is neutral-to-weak, not showing an oversold bounce signal. Key levels: Pivot 2.687 is the first reclaim level bulls need. Resistance: 2.904 (R1) then 3.039 (R2). Support: 2.469 (S1) then 2.334 (S2). With price ~2.61–2.62 post-market, it’s trading below the pivot, implying rallies may fade into resistance unless it clears 2.69. Quant pattern note: Similar-pattern stats imply modest positive drift (≈+0.94% next day; +1.75% next week; +2.12% next month), but that is not strong enough to outweigh the still-bearish trend structure.
Intellectia Proprietary Trading Signals

scheduled for 2026-02-11 pre-market could serve as a volatility catalyst.
suggests the market expects large swings; for a new entry, that often means paying up for uncertainty.
Latest quarter: 2025/Q3. Growth: Revenue increased to 3,609,000 (+2719.53% YoY), showing explosive top-line growth off a low base. Profitability/efficiency: Net income fell to 83,269,000 (-3165.87% YoY), EPS fell to 2.23 (-158.38% YoY), and gross margin dropped to 65.95 (-142.42% YoY). Net/net: the quarter shows strong revenue expansion but materially weaker profitability metrics, which is not the profile of a clean, low-risk buy right now.
No analyst rating / price target change data was provided. Practically, this typically means limited Wall Street coverage; the ‘pros’ case leans on turnaround/catalyst upside and revenue acceleration, while the ‘cons’ case is limited external validation plus weak/volatile profitability and a bearish technical setup.
